Top Markets
#1 Audiera Audiera +41.43%
#2 Arowana Arowana +34.23%
#3 Fabric Protocol Fabric Protocol +30.69%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.88%
#5 Bitcoin Cash Bitcoin Cash +29.70%
#6 Tutorial Tutorial +29.64%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +27.77%
#8 GALA GALA +26.96%
#9 Zora Zora +24.83%
#10 Ethena Staked ENA Ethena Staked ENA +24.08%
Coin of the day
Audiera Audiera
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Classement en actions #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Prix de l'action
$3.09
Capitalisation boursière
$58.82M
Changement (1 jour)
0.33%
Changement (1 an)
-73.01%
Pays
US
Échange Elicio Therapeutics, Inc. (ELTX)

Catégorie

Healthcare
EPS pour Elicio Therapeutics, Inc. (ELTX)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Elicio Therapeutics, Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Elicio Therapeutics, Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH